SuicidalityTSPedCovidNCT07302295
Analysis of Suicidal Behavior Among Children and Adolescents in the Auvergne-Rhone-Alpes Region During the Covid 19 Pandemic Period
A study testing Aggregated data collection and Data collection and qualitative interview in people with Suicidality and COVID -19, run by Hospices Civils de Lyon at 4 sites in France.
Trial summary
In 2020, the world is hit by a global health crisis due to a pandemic following the appearance of Sars-cov-2 or "covid-19". This pandemic was accompanied by a constant fear of contamination and death, relayed by the media. In France, the government proposed in response to the arrival of this virus on French territory. Read more about this study
- Who is it for?
- Ages 8 to 18 years
- Conditions the study is for
- Suicidality, COVID -19
- What is being tested?
- Aggregated data collection and Data collection and qualitative interview
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 6,500 participants
- Where
- 4 sitesFrance
- Study dates
- 6 May 2026to Feb 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 8 to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- The population (subjects and controls) will be divided into age categories:
- Pre-adolescents (≥ 8 years and < 11 years)
- Adolescents (≥ 11 years and < 15 years)
- Older adolescents (≥ 15 years and < 18 years)
- Subjects with suicidal behavior during the health crisis (Group 1):
- Age > 8 years and < 18 years during the period 2020 to 2022.
Show all 15Show fewer
- Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2020, 2021, and/or 2022 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent).
- Subjects with suicidal behavior during the health crisis with qualitative interviews (Group 1b):
- Age > 8 years and < 18 years during the period 2020 to 2022.
- Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2020, 2021, and/or 2022 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent).
- Randomly selected from the population of Group 1.
- For whom the parent(s) and/or the subject have signed informed consent.
- Controls with suicidal behavior before the health crisis (Group 2):
- Age > 8 years and < 18 years during the period 2018 to 2019.
- Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2018 and/or 2019 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent).
Who cannot join
- Subjects with Suicidal Behavior during the Health Crisis with and without Qualitative Interviews (Group 1 and 1b):
- Admitted to pediatric emergency services or hospitalized in a healthcare facility (university hospital center, general hospital) in the AURA region for a psychiatric reason other than suicidal behavior during the period from 2020 to 2022.
- Controls with Suicidal Behavior before the Health Crisis (Group 2):
- Admitted to pediatric emergency services or hospitalized in a healthcare facility (university hospital center, general hospital) in the AURA region for a psychiatric reason other than suicidal behavior during the period from 2018 to 2019.
- Intercurrent illness with a life expectancy of less than 24 hours.
- For Group 1:
Show all 11Show fewer
- Pregnant, postpartum, or breastfeeding women.
- Persons deprived of liberty by judicial or administrative decision.
- Adults subject to a legal protection measure (guardianship, curatorship).
- Persons not affiliated with a social security scheme or beneficiaries of a similar scheme.
- Persons who do not understand and do not speak French.
Trial locations and contacts
4 sites in 1 country. Contact the study team or a site near you to ask about taking part.
France4 sites, 4 recruiting
- Recruiting
Hospices Civils de Lyon - Hôpital Femme Mère Enfant- Service de pédopsychiatrie de l'enfant et de l'adolescent
Bron, 69500
Elise MAMIMOUE, Dr, 472129567 ext. +33, elise.mamimoue@chu-lyon.fr
Elise MAMIMOUE, Dr
- Not yet recruiting
CHU de Clermont-Ferrand - Service de psychiatrie de l'enfant et de l'adolescent
Clermont-Ferrand, 63000
Jonathan Lachal, Pr, 473750750 ext. +33, jonathan.lachal@chu-clermontferrand.fr
Jonathan LACHAL, Pr
- Not yet recruiting
CHU de Grenoble - Service de psychiatrie de l'enfant et de l'adolescent
Grenoble, 38043
Stéphanie Bioulac, Dr, +330476767575 ext. +33, SBioulacrogier@chu-grenoble.fr
Stéphanie BIOULAC, Dr
- Not yet recruiting
CHU de Saint-Etienne - Urgences psychiatriques
Saint-Etienne, 42100
Catherine Massoubre, Pr, +33477828000 ext. +33, catherine.massoubre@chu-st-etienne.fr
Catherine Massoubre, Pr
About this study
Official title: Clinical and Socioeconomic Characteristics of Suicidal Behaviour in Children and Adolescents During the Covid19 Pandemic Period in Auvergne-Rhône-Alpes. Prospective Quantitative and Qualitative Study
In 2020, the world is hit by a global health crisis due to a pandemic following the appearance of Sars-cov-2 or "covid-19". This pandemic was accompanied by a constant fear of contamination and death, relayed by the media. In France, the government proposed in response to the arrival of this virus on French territory. This policy was implemented in different ways over 3 distinct periods: strict containment at the start of the epidemic, then a "lighter" one, and finally a period of social restrictions without between these periods. This policy had a direct and rapid impact on the population's daily routines. Children and adolescents, are more susceptible to psychological trauma, as stress has a direct and psychic development. Studies have shown deleterious impact of the French health situation on the paediatric population. They point to an increase of psychological disorders such as depression and anxiety in the under -20s population, and an increase in suicidal gestures over the 2020-2021 period, with rates remaining higher than in previous years. Suicide is the 2nd leading cause of death in the population aged 15-24.
Studies continue to focus on the incidence of suicidal gestures of suicidal gestures and psychological disorders, and few of them examine the factors linked to the increase in these incidences, the traumatic impact or the story of the trajectory. Similarly, the few studies focus only on the population aged 12 and over, and in some cases, do not distinguish between age groups (15-24 or under 20).
Read more
Investigators believe that the various periods of social restrictions and eco-anxiety caused by the pandemic may have influenced suicidal behaviour in this population.
The main objective of this study is to investigate the clinical and socio-economic characteristics of the pediatric population who experienced suicidal behaviors in the Auvergne Rhone Alpes region during the covid 19 pandemic.
- Conditions
- Suicidality, COVID -19
- Being tested
- Aggregated data collection, Data collection and qualitative interview
- Keywords
- suicide, pediatrics, covid-19
- Medical subject headings
- Suicidal Ideation, COVID-19, Suicide
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Aggregated data collectionOther
The demographic and diagnostic characteristics will be collected in aggregate form nafrom digital services departments or medical information departments of participating hospitals.
Data collection and qualitative interviewOther
The psychopathological and socioeconomic characteristics will be collected. For subjects who agreed, they will participate in interviews and/or focus groups. Parent's subjects who agreed will be part of focus groups too.
| Study group | Role | What they receive |
|---|---|---|
| Subjects with suicidal behaviors during the health crisis of covid-19 between 2020 and 2022 (group1) | Experimental | * Name : Group 1
* Subjects with Suicidal Behaviors (suicidal conduct, ideas, self-harm with suicidal intention) during the Health Crisis of Covid-19 and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region participating between 2020 and 2022.
* Age ≥ 8 years old and < 18 years old between 2020 and 2022. Receives: Other: Aggregated data collection |
| Subjects with suicidal behaviors during covid-19 period with qualitative interviews (group 1b) | Experimental | * Name : Group 1b
* Subjects with Suicidal Behaviors (suicidal conduct, ideas, self-harm with suicidal intention) during the Health Crisis of Covid-19 and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region participating between 2020 and 2022 and theirs parents
* Age ≥ 8 years old and < 18 years old between 2020 and 2022 for subjects.
* One or both parents
* Subjects who agreed to participate in interviews and/or focus groups and gave their consent to be part of the group of patients participating in a qualitative interview (volunteer subjects).
* Parent's subjects agreed their consent to be part of the group This group is estimated to 150 subjects and 300 parents max. Receives: Other: Data collection and qualitative interview |
| Subjects control with suicidal behaviors before the health crisis (Group 2). | Experimental | * Name: group 2
* Subjects with suicidal behaviors (suicidal conduct, ideas, self-harm with suicidal intention) before the health crisis of Covid-19 (2018 and or 2019) and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region
* Age ≥ 8 years old and < 18 years old between 2018 and 2019 Receives: Other: Aggregated data collection |
What is being measured
The primary outcome is the main question the study is designed to answer.
Demographic and diagnostic characteristics
The following demographic and diagnostic characteristics will be collected in aggregate form for the entire population of children and adolescents who engaged in suicidal behavior during the health crisis and in the two preceding years:
- Age, gender, place of residence,
- ICD-10 diagnosis and referral,
- Type of suicidal behavior (ideation, self-harm, suicide attempt),
- Periods of social restrictions (lockdown, curfew, vaccine pass).
Measured: Baseline
Secondary outcomes (6)
Number of patients aged 8-17 and 11month admitted to pediatric emergency
Number of patients aged 8-17 and 11month admitted to pediatric emergency rooms or hospitalized in a continuous care/intensive care unit of university hospitals (CHU) or general hospitals (CH) for suicidal behavior during the COVID-19 pandemic period of 2020, 2021, and 2022, and those in the two preceding years: 2018 and 2019.
Measured: Baseline
Psychopathological and socio-economic characteristics
The following psychopathological and socio-economic characteristics will be collected:
- Age, sex, place of residence,
- Family situation and intrafamilial relationships
- Type of suicidal behavior and description (ideation, self-harm, suicide attempt)
- Periods of social restrictions (lockdown, curfew, vaccination pass)
- Leisure time and type of leisure activities/hobbies
- Education
- Relationship with peers
- Previous and current psychiatric diagnosis (according to ICD-10)
- Personal and family psychiatric history
- Personal medical history
- Pharmacological and psychological treatment; Type of care
Measured: Baseline
Scores to CRIES
Scores on the Children's Revised Impact of Events Scale (CRIES-13) (Horowitz et al., 1979; Brunet et al., 2003) among children from a representative sample of the cohort (group 1b, volunteer subjects).
Measured: Up to 3 months
CAS scale
Scores on the Climate Anxiety Scale (CAS) (Clayton and Karazsia, 2020; Mouguiama-Daouda et al., 2022) among children from a representative sample of the cohort (group 1b, volunteer subjects).
Measured: Up to 3 months
Qualitative interview
Semi-structured interviews with children and adolescents with suicidal behavior from a representative sample of the cohort.
Subjects who agreed to interviews. We will try to have a sample of volunteers from Group 1 who can be representative of our population (care orientation, age, personal psychiatric history, and place of residence.)
Measured: Up to 3 months
Results to focus groups (parent's subjects, group 1b)
Focus groups with the parents of children and adolescents with suicidal behavior from a representative sample of the cohort (randomly selected).
Measured: Up to 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Dec 2025
- Study start6 May 2026
- Primary completionNov 2027 (estimated)
- Study completionFeb 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SuicidalityStudies of the same condition, open and under way.
- More trials run by Hospices Civils de LyonThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Single group
- Model description
- Multicenter descriptive study, involving retrospective data collection with a questionnaire and prospective qualitative evaluations. Research involving human subjects outside of health products as mentioned in Article L1121-1, 2° of the Public Health Code
- Masking
- None (open label)
- Enrolment
- 6,500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hospices Civils de Lyon
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07302295
- Sponsor's protocol ID
- 69HCL22_1175
- Other IDs
- 2023-A02237-38
- Acronym
- TSPedCovid
- Status last verified
- May 2026
- First submitted
- 24 Nov 2025
- Last updated
- 18 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical and Socioeconomic Characteristics of Suicidal Behaviour in Children and Adolescents During the Covid19 Pandemic Period in Auvergne-Rhône-Alpes. Prospective Quantitative and Qualitative Study
- ClinicalTrials.gov ID
- NCT07302295
- Acronym / sponsor ID
- TSPedCovid / 69HCL22_1175
- Conditions
- Suicidality, COVID -19
- Keywords
- suicide, pediatrics, covid-19
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 6,500 participants (estimated)
- Lead sponsor
- Hospices Civils de LyonUniversity, hospital or other
- Study start
- 6 May 2026 (actual)
- Primary completion
- Nov 2027 (estimated)
- Study completion
- Feb 2028 (estimated)
- First posted
- 24 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In 2020, the world is hit by a global health crisis due to a pandemic following the appearance of Sars-cov-2 or "covid-19". This pandemic was accompanied by a constant fear of contamination and death, relayed by the media. In France, the government proposed in response to the arrival of this virus on French territory. This policy was implemented in different ways over 3 distinct periods: strict containment at the start of the epidemic, then a "lighter" one, and finally a period of social restrictions without between these periods. This policy had a direct and rapid impact on the population's daily routines. Children and adolescents, are more susceptible to psychological trauma, as stress has a direct and psychic development. Studies have shown deleterious impact of the French health situation on the paediatric population. They point to an increase of psychological disorders such as depression and anxiety in the under -20s population, and an increase in suicidal gestures over the 2020-2021 period, with rates remaining higher than in previous years. Suicide is the 2nd leading cause of death in the population aged 15-24.
Studies continue to focus on the incidence of suicidal gestures of suicidal gestures and psychological disorders, and few of them examine the factors linked to the increase in these incidences, the traumatic impact or the story of the trajectory. Similarly, the few studies focus only on the population aged 12 and over, and in some cases, do not distinguish between age groups (15-24 or under 20).
Investigators believe that the various periods of social restrictions and eco-anxiety caused by the pandemic may have influenced suicidal behaviour in this population.
The main objective of this study is to investigate the clinical and socio-economic characteristics of the pediatric population who experienced suicidal behaviors in the Auvergne Rhone Alpes region during the covid 19 pandemic.
Study design
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 3
- Model description
- Multicenter descriptive study, involving retrospective data collection with a questionnaire and prospective qualitative evaluations. Research involving human subjects outside of health products as mentioned in Article L1121-1, 2° of the Public Health Code
| Arm | Type | Receives |
|---|---|---|
| Subjects with suicidal behaviors during the health crisis of covid-19 between 2020 and 2022 (group1) | Experimental | Other: Aggregated data collection* Name : Group 1 * Subjects with Suicidal Behaviors (suicidal conduct, ideas, self-harm with suicidal intention) during the Health Crisis of Covid-19 and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region participating between 2020 and 2022. * Age ≥ 8 years old and < 18 years old between 2020 and 2022. |
| Subjects with suicidal behaviors during covid-19 period with qualitative interviews (group 1b) | Experimental | Other: Data collection and qualitative interview* Name : Group 1b * Subjects with Suicidal Behaviors (suicidal conduct, ideas, self-harm with suicidal intention) during the Health Crisis of Covid-19 and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region participating between 2020 and 2022 and theirs parents * Age ≥ 8 years old and < 18 years old between 2020 and 2022 for subjects. * One or both parents * Subjects who agreed to participate in interviews and/or focus groups and gave their consent to be part of the group of patients participating in a qualitative interview (volunteer subjects). * Parent's subjects agreed their consent to be part of the group This group is estimated to 150 subjects and 300 parents max. |
| Subjects control with suicidal behaviors before the health crisis (Group 2). | Experimental | Other: Aggregated data collection* Name: group 2 * Subjects with suicidal behaviors (suicidal conduct, ideas, self-harm with suicidal intention) before the health crisis of Covid-19 (2018 and or 2019) and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region * Age ≥ 8 years old and < 18 years old between 2018 and 2019 |
Who may qualify
- Ages
- 8 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (15 listed)
- The population (subjects and controls) will be divided into age categories:
- Age > 8 years and < 18 years during the period 2020 to 2022.
- Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2020, 2021, and/or 2022 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent).
- Subjects with suicidal behavior during the health crisis with qualitative interviews (Group 1b):
- Age > 8 years and < 18 years during the period 2020 to 2022.
Key exclusion criteria (11 listed)
- Subjects with Suicidal Behavior during the Health Crisis with and without Qualitative Interviews (Group 1 and 1b):
- Admitted to pediatric emergency services or hospitalized in a healthcare facility (university hospital center, general hospital) in the AURA region for a psychiatric reason other than suicidal behavior during the period from 2020 to 2022.
- Admitted to pediatric emergency services or hospitalized in a healthcare facility (university hospital center, general hospital) in the AURA region for a psychiatric reason other than suicidal behavior during the period from 2018 to 2019.
- Intercurrent illness with a life expectancy of less than 24 hours.
- Pregnant, postpartum, or breastfeeding women.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Aggregated data collectionThe demographic and diagnostic characteristics will be collected in aggregate form nafrom digital services departments or medical information departments of participating hospitals. | Other | Subjects control with suicidal behaviors before the health crisis (Group 2)., Subjects with suicidal behaviors during the health crisis of covid-19 between 2020 and 2022 (group1) |
| Data collection and qualitative interviewThe psychopathological and socioeconomic characteristics will be collected. For subjects who agreed, they will participate in interviews and/or focus groups. Parent's subjects who agreed will be part of focus groups too. | Other | Subjects with suicidal behaviors during covid-19 period with qualitative interviews (group 1b) |
Primary outcome
Demographic and diagnostic characteristics
Time frame: Baseline
The following demographic and diagnostic characteristics will be collected in aggregate form for the entire population of children and adolescents who engaged in suicidal behavior during the health crisis and in the two preceding years: * Age, gender, place of residence, * ICD-10 diagnosis and referral, * Type of suicidal behavior (ideation, self-harm, suicide attempt), * Periods of social restrictions (lockdown, curfew, vaccine pass).
6 secondary outcomes
Number of patients aged 8-17 and 11month admitted to pediatric emergency
Time frame: Baseline
Psychopathological and socio-economic characteristics
Time frame: Baseline
Scores to CRIES
Time frame: Up to 3 months
CAS scale
Time frame: Up to 3 months
Qualitative interview
Time frame: Up to 3 months
Results to focus groups (parent's subjects, group 1b)
Time frame: Up to 3 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 May 2026.
Related trials for Suicidality
Not yet recruiting
A Pre-post Study of a Lethal Means Safety Planning Intervention for Youth at Elevated Suicide Risk in the Emergency Department
Suicidal Ideas, Suicidal Ideation
RecruitingObservational study
Student Precarity and Psychiatry
Depressive Disorder, Major, Generalized Anxiety Disorder
Not yet recruiting
SERENE Low-Intensity Focused Ultrasound for Cognitive Control
Suicidal Ideation, Cognitive Control
Not yet recruiting
A MRT to Optimize a JITAI for Alcohol Craving and Suicide Ideation
Alcohol Use Disorder (AUD), Suicide Ideation
Enrolling by invitation
Pilot Study of a Modified Safety Planning Intervention for Elementary School-Aged Children - Main Study
Suicidal Ideation, Suicidal Behaviors
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
4 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Aggregated data collection and Data collection and qualitative interview in people with Suicidality and COVID -19, run by Hospices Civils de Lyon at 4 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 15 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 18 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 4 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Elise MAMIMOUE, Dr (472129567 ext. +33, Elise.mamimoue@chu-lyon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Demographic and diagnostic characteristics (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2026.